Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 16 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
GYNIMMO from Mechelen, company number BE0846554731, closed financial year 2025 with a result of € 5,662 after tax. For that financial year GYNIMMO recorded a gross margin of € 27,672 and equity of € 9,374. Compared with financial year 2024, the result moved from € 5,333 to € 5,662. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.
€ 9,374
▲ 153% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 5,662
▲ 6% vs 2024
Profit after tax over the fiscal year.
€ 31,083
▼ 18% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -9,176.
Debts at end 2025
€ 57,356
▼ 10% vs 2024
€ 6,850 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 2,629
▼ 74% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 25,143 | € 23,112 | € 27,520 | € 27,672 | ▲ 1% |
| Profit after taxes | € 3,824 | € 1,141 | € 5,333 | € 5,662 | ▲ 6% |
| Equity | € -2,763 | € -1,621 | € 3,712 | € 9,374 | ▲ 153% |
| Total debts | € 274,817 | € 276,727 | € 273,693 | € 249,156 | ▼ 9% |
| Cash | € 8,852 | € 23,864 | € 38,123 | € 31,083 | ▼ 18% |
| Land & buildings | € 262,684 | € 250,723 | € 238,763 | € 226,803 | ▼ 5% |
| Retained profit | € -21,313 | € -20,171 | € -14,838 | € -9,176 | ▲ € 5,662 |
| Bank debt | € 208,720 | € 202,589 | € 63,957 | € 57,356 | ▼ 10% |
| Balance sheet total | € 272,054 | € 275,105 | € 277,405 | € 258,529 | ▼ 7% |
Key figures of GYNIMMO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GYNIMMO?
What happened at GYNIMMO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 5,662 (▲ 6% vs 2024). filed late Source: NBB ↗
- New establishment in Mechelen. KBO
- Start of the company according to the CBE. KBO
In short
From € 3,824 profit in 2022 to € 5,662 profit in 2025.
Best year ever: 2025, with € 5,662 profit.
Management
The stake of Dr. Stefanie Verhelst, Dr. Ine Tavano comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
GYNIMMOBehind GYNIMMO are Jan Bosteels and Jan Baekelandt. The shares are held by Dr. Stefanie Verhelst (25%) and Dr. Ine Tavano.
Directors
According to the 2025 annual accounts
Jan Bosteels
Director
Also active at: GYNIM, Vereniging Geneesheren-Specialisten van Imeldaziekenhuis
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Schuttersvest 47
2800 Mechelen
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0846.554.731
- VAT number
- BE 0846.554.731
- Registered office
- Schuttersvest 47, 2800 Mechelen
- Names & denominations
- GYNIMMO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 June 2012
- Peppol
- Active · Active since 17 Dec 2025